Your browser doesn't support javascript.
loading
Inside-Out of Complement in Cancer.
Kolev, Martin; Das, Madhumita; Gerber, Monica; Baver, Scott; Deschatelets, Pascal; Markiewski, Maciej M.
Afiliación
  • Kolev M; Discovery, Apellis Pharmaceuticals, Waltham, MA, United States.
  • Das M; Discovery, Apellis Pharmaceuticals, Waltham, MA, United States.
  • Gerber M; Legal Department, Apellis Pharmaceuticals, Waltham, MA, United States.
  • Baver S; Medical Affairs, Apellis Pharmaceuticals, Waltham, MA, United States.
  • Deschatelets P; Discovery, Apellis Pharmaceuticals, Waltham, MA, United States.
  • Markiewski MM; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX, United States.
Front Immunol ; 13: 931273, 2022.
Article en En | MEDLINE | ID: mdl-35860237
The role of complement in cancer has received increasing attention over the last decade. Recent studies provide compelling evidence that complement accelerates cancer progression. Despite the pivotal role of complement in fighting microbes, complement seems to suppress antitumor immunity via regulation of host cell in the tumor microenvironment. Although most studies link complement in cancer to complement activation in the extracellular space, the discovery of intracellular activation of complement, raises the question: what is the relevance of this process for malignancy? Intracellular activation is pivotal for the survival of immune cells. Therefore, complement can be important for tumor cell survival and growth regardless of the role in immunosuppression. On the other hand, because intracellular complement (the complosome) is indispensable for activation of T cells, these functions will be essential for priming antitumor T cell responses. Here, we review functions of complement in cancer with the consideration of extra and intracellular pathways of complement activation and spatial distribution of complement proteins in tumors and periphery and provide our take on potential significance of complement as biomarker and target for cancer therapy.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas del Sistema Complemento / Neoplasias Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas del Sistema Complemento / Neoplasias Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos